Gonzalo Pizarro Selected Research

Metoprolol (Toprol-XL)

10/2021	Coexistence of transmural and lateral wavefront progression of myocardial infarction in the human heart.
1/2021	Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study.
12/2020	Beta-blocker effect on ST-segment: a prespecified analysis of the EARLY-BAMI randomised trial.
11/2020	Left ventricular functional recovery of infarcted and remote myocardium after ST-segment elevation myocardial infarction (METOCARD-CNIC randomized clinical trial substudy).
10/2020	Five-Year Outcomes and Prognostic Value of Feature-Tracking Cardiovascular Magnetic Resonance in Patients Receiving Early Prereperfusion Metoprolol in Acute Myocardial Infarction.
1/2020	Metoprolol blunts the time-dependent progression of infarct size.
1/2019	Effect of Early Metoprolol During ST-Segment Elevation Myocardial Infarction on Left Ventricular Strain: Feature-Tracking Cardiovascular Magnetic Resonance Substudy From the METOCARD-CNIC Trial.
1/2017	Neutrophil stunning by metoprolol reduces infarct size.
6/2016	Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.
5/2016	Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gonzalo Pizarro Research Topics

Disease

16	ST Elevation Myocardial Infarction 10/2021 - 10/2012
15	Infarction (Infarctions) 10/2021 - 10/2012
12	Myocardial Infarction 01/2022 - 10/2012
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 07/2014
4	Ischemia 01/2020 - 07/2014
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2021 - 10/2018
3	Cardiac Arrhythmias (Arrythmia) 01/2021 - 04/2013
3	Reperfusion Injury 01/2020 - 01/2017
3	Atrioventricular Block 06/2016 - 10/2012
2	Cicatrix (Scar) 10/2021 - 01/2021
2	Fibrosis (Cirrhosis) 01/2021 - 01/2014
2	Cardiotoxicity 01/2021 - 01/2019
2	Ventricular Tachycardia 01/2021 - 01/2014
2	Pulmonary Hypertension 01/2016 - 10/2013
2	Heart Failure 06/2014 - 06/2008
1	Human Influenza (Influenza) 03/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Hemorrhage 11/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Ventricular Fibrillation 01/2020
1	Disease Progression 10/2017
1	Coronary Occlusion 05/2017
1	Inflammation (Inflammations) 01/2017
1	Vascular Remodeling 01/2016
1	Ventricular Remodeling 01/2016
1	Hypoxia (Hypoxemia) 07/2014
1	Left Ventricular Dysfunction 06/2014
1	Cardiogenic Shock 10/2013
1	Tachycardia (Tachyarrhythmias) 04/2013

Drug/Important Bio-Agent (IBA)

15	Metoprolol (Toprol-XL)FDA LinkGeneric 10/2021 - 10/2012
4	GadoliniumIBA 10/2021 - 01/2017
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018 - 07/2014
2	Infliximab (Remicade)FDA Link 05/2021 - 11/2018
2	AnthracyclinesIBA 01/2021 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2019
2	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2018 - 01/2016
2	Vasodilator Agents (Vasodilators)IBA 01/2016 - 10/2013
1	VaccinesIBA 03/2021
1	omega-Chloroacetophenone (Mace)IBA 10/2020
1	AfatinibIBA 01/2020
1	mirabegronIBA 01/2018
1	BRL 37344IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 08/2017
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017
1	LipidsIBA 01/2017
1	EicosanoidsIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2016
1	Biological ProductsIBA 01/2016
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 07/2014
1	Mitochondrial Permeability Transition PoreIBA 07/2014
1	Cyclophilins (Cyclophilin)IBA 07/2014
1	Indicators and Reagents (Reagents)IBA 01/2014
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2013
1	Bronchodilator Agents (Bronchodilators)IBA 10/2012
1	Pharmaceutical PreparationsIBA 10/2012

Therapy/Procedure

10	Percutaneous Coronary Intervention 01/2021 - 10/2012
7	Therapeutics 01/2022 - 06/2008
2	Catheter Ablation 01/2021 - 04/2013
1	Drug Therapy (Chemotherapy) 01/2020
1	Immunotherapy 01/2020
1	Complementary Therapies (Alternative Medicine) 10/2018
1	Intravenous Administration 01/2018